KLP Kapitalforvaltning’s West Pharmaceutical WST Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$10.7M Hold
28,820
– – 0.03% 375
2026
Q2
$10.3M Buy
28,820
+1,300
+5% +$397K 0.03% 383
2026
Q1
$6.9M Buy
27,520
+2,120
+8% +$527K 0.03% 428
2025
Q4
$6.99M Hold
25,400
– – 0.03% 433
2025
Q3
$6.66M Hold
25,400
– – 0.03% 439
2025
Q2
$5.56M Buy
25,400
+500
+2% +$107K 0.02% 459
2025
Q1
$5.57M Buy
24,900
+600
+2% +$165K 0.03% 461
2024
Q4
$7.96M Buy
+24,300
New +$7.65M 0.04% 386

Other funds holding WST

KLP Kapitalforvaltning's WST Position: Q3 2026 in Review

KLP Kapitalforvaltning held its West Pharmaceutical (WST) position steady in Q3 2026 at 28,820 shares worth $10.7M. The position accounts for 0.03% of the portfolio, ranked #375.

KLP Kapitalforvaltning first reported a position in WST in Q4 2024 and has held it in 8 quarters since. 606 funds tracked by Wall St. Rank hold WST as of Q3 2026.

  • KLP Kapitalforvaltning held 28,820 shares of West Pharmaceutical worth $10.7M as of Q3 2026.
  • KLP Kapitalforvaltning left its West Pharmaceutical share count unchanged in Q3 2026.
  • West Pharmaceutical made up 0.03% of KLP Kapitalforvaltning's portfolio in Q3 2026, its #375 holding.
  • KLP Kapitalforvaltning first reported a position in West Pharmaceutical in Q4 2024 and has held it in 8 quarters since.
  • 606 funds tracked by Wall St. Rank held West Pharmaceutical as of Q3 2026.

Based on KLP Kapitalforvaltning's 13F filing for Q3 2026, filed 10 Nov 2026.